Company intelligence / Profile preview

Lei Yun Shang

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Commercial

Overview

Lei Yun Shang is a leading heritage brand in China’s traditional Chinese medicine sector with nearly 300 years of history. It manufactures a wide range of TCM products for various indications including liver disease and cardiovascular conditions. The company integrates modern R&D with classical formulations and has received national recognition for quality control and innovation[1][2]. No Western-style clinical trial results are publicly reported.

Therapeutic areas: NephrologyOncologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeHerbal medicineTraditional Chinese medicine compound preparations
Industry: Pharma

Drug pipeline

18 assets

fufang congrong yizhi

17 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Lei Yun Shang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lei Yun Shang.

Explore the full profile